Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-017379
Filing Date
2021-04-29
Accepted
2021-04-29 16:49:02
Documents
1
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6677
  Complete submission text file 0000899243-21-017379.txt   8843
Mailing Address PRUDENTIAL TOWER SUITE 1555, 800 BOYLSTON ST. BOSTON MA 02199
Business Address PRUDENTIAL TOWER SUITE 1555, 800 BOYLSTON ST. BOSTON MA 02199 617-351-2590
Longwood Fund III, L.P. (Reporting) CIK: 0001640546 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21871551

Mailing Address 800 BOYLSTON ST, SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON ST, SUITE 1555 BOSTON MA 02199 6173512590
Longwood Fund III GP, LLC (Reporting) CIK: 0001762853 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21871552

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations